Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. (Q50483095)
Jump to navigation
Jump to search
scientific article published in July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. |
scientific article published in July 2003 |
Statements
1 reference
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. (English)
1 reference
1 reference
T J Creed
1 reference
M R Norman
1 reference
C S J Probert
1 reference
R F Harvey
1 reference
I S Shaw
1 reference
J Smithson
1 reference
J Anderson
1 reference
M Moorghen
1 reference
J Gupta
1 reference
N A Shepherd
1 reference
S D Hearing
1 reference
1 July 2003
1 reference
18
1 reference
1
1 reference
65-75
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference